{"id":114022,"date":"2024-04-08T15:40:03","date_gmt":"2024-04-08T10:10:03","guid":{"rendered":"http:\/\/finservwealth.com\/astrazeneca-daiichi-drug-gets-broad-tumor-approval-in-us\/"},"modified":"2024-04-08T15:40:03","modified_gmt":"2024-04-08T10:10:03","slug":"astrazeneca-daiichi-drug-gets-broad-tumor-approval-in-us","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/astrazeneca-daiichi-drug-gets-broad-tumor-approval-in-us\/","title":{"rendered":"AstraZeneca, Daiichi drug gets broad tumor approval in US"},"content":{"rendered":"<p> The US Food and Drug Administration cleared the medicine for patients who have HER2-positive solid tumors that have spread or can\u00e2\u20ac\u2122t be removed with surgery, the company said. These patients have already received prior treatment and don\u00e2\u20ac\u2122t have any good alternatives.<\/p><div id=\"finse-1288731514\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/business\/astrazeneca-daiichi-drug-gets-broad-tumor-approvalus_17519241.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The US Food and Drug Administration cleared the medicine for patients who have HER2-positive solid tumors that have spread or can\u00e2\u20ac\u2122t be removed with surgery, the company said. These patients have already received prior treatment and don\u00e2\u20ac\u2122t have any good alternatives. The US Food and Drug Administration cleared the medicine for patients who have HER2-positive solid tumors that have spread or can\u00e2\u20ac\u2122t be removed with surgery, the company said. These patients have already received prior treatment and don\u00e2\u20ac\u2122t have any good alternatives.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/business\/astrazeneca-daiichi-drug-gets-broad-tumor-approvalus_17519241.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> The US Food and Drug Administration cleared the medicine for patients who have HER2-positive solid tumors that have spread or can\u00e2\u20ac\u2122t be removed with surgery, the company said. These patients have already received prior treatment and don\u00e2\u20ac\u2122t have any good alternatives.<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/business\/astrazeneca-daiichi-drug-gets-broad-tumor-approvalus_17519241.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The US Food and Drug Administration cleared the medicine for patients who have HER2-positive solid tumors that have spread or can\u00e2\u20ac\u2122t be removed with surgery, the company said. These patients have already received prior treatment and don\u00e2\u20ac\u2122t have any good alternatives. The US Food and Drug Administration cleared the medicine for patients who have HER2-positive solid tumors that have spread or can\u00e2\u20ac\u2122t be removed with surgery, the company said. These patients have already received prior treatment and don\u00e2\u20ac\u2122t have any good alternatives.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/business\/astrazeneca-daiichi-drug-gets-broad-tumor-approvalus_17519241.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> The US Food and Drug Administration cleared the medicine for patients who have HER2-positive solid tumors that have spread or can\u00e2\u20ac\u2122t be removed with surgery, the company said. These patients have already received prior treatment and don\u00e2\u20ac\u2122t have any good alternatives.<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-114022","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2024\/200x200\/A\/Astrazeneca_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/114022","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=114022"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/114022\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=114022"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=114022"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=114022"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}